• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病血浆生物标志物的遗传度:一项核孪生家族研究设计。

Heritability of Alzheimer's disease plasma biomarkers: A nuclear twin family design.

作者信息

Rousset Rebecca Z, den Braber Anouk, Verberk Inge M W, Boonkamp Lynn, Wilson David H, Ligthart Lannie, Teunissen Charlotte E, de Geus Eco J C

机构信息

Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.

Alzheimer Center, Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.

出版信息

Alzheimers Dement. 2025 Jan;21(1):e14269. doi: 10.1002/alz.14269. Epub 2024 Nov 26.

DOI:10.1002/alz.14269
PMID:39588748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11775461/
Abstract

INTRODUCTION

Alzheimer's disease (AD) is a highly heritable disease (60%-80%). Amyloid beta (Aβ) 42/40, neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP) are plasma biomarkers for AD. Clinical biomarker research would be served by an understanding of the sources of variance in these markers.

METHODS

Blood concentrations of Aβ42/40, NfL, and GFAP of twins and their families (monozygotic twins: 1574, dizygotic twins: 1266, other: 3657) were analyzed on the Simoa HD-X. Twin-family models were used to estimate proportional genetic contributions to the variance in biomarker levels.

RESULTS

Heritability estimates were 16% for Aβ42/40, 42% for NfL, and 60% for GFAP. NfL and GFAP were significantly correlated with each other (0.37) but not with Aβ42/40.

DISCUSSION

The heritability of Aβ42/40 (16%) is lower than the heritability of AD, suggesting strong environmental influences on this biomarker. The lack of correlation between NfL/GFAP and Aβ42/40 indicates these markers may be on different biological pathways.

HIGHLIGHTS

Heritability is found for glial fibrillary acidic protein (60%), neurofilament light chain (42%), and amyloid beta (Aβ) 42/40 (16%) plasma levels. Aβ42/40 plasma levels are sensitive to person-specific environmental influences.

摘要

引言

阿尔茨海默病(AD)是一种高度可遗传的疾病(遗传率为60%-80%)。淀粉样β蛋白(Aβ)42/40、神经丝轻链(NfL)和胶质纤维酸性蛋白(GFAP)是AD的血浆生物标志物。了解这些标志物的变异来源将有助于临床生物标志物研究。

方法

在Simoa HD-X上分析了双胞胎及其家庭成员(同卵双胞胎:1574例,异卵双胞胎:1266例,其他:3657例)的血液中Aβ42/40、NfL和GFAP的浓度。采用双生子-家系模型来估计生物标志物水平变异的遗传贡献率。

结果

Aβ42/40的遗传率估计为16%,NfL为42%,GFAP为60%。NfL和GFAP彼此显著相关(0.37),但与Aβ42/40不相关。

讨论

Aβ42/40的遗传率(16%)低于AD的遗传率,表明该生物标志物受环境影响较大。NfL/GFAP与Aβ42/40之间缺乏相关性,表明这些标志物可能处于不同的生物学途径。

要点

发现胶质纤维酸性蛋白(60%)、神经丝轻链(42%)和淀粉样β蛋白(Aβ)42/40(16%)的血浆水平具有遗传率。Aβ42/40血浆水平对个体特异性环境影响敏感。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcf1/11775461/648cf5e9ffd2/ALZ-21-e14269-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcf1/11775461/a3871dad14c4/ALZ-21-e14269-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcf1/11775461/5d9301d6a0e9/ALZ-21-e14269-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcf1/11775461/72dee13389b5/ALZ-21-e14269-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcf1/11775461/648cf5e9ffd2/ALZ-21-e14269-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcf1/11775461/a3871dad14c4/ALZ-21-e14269-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcf1/11775461/5d9301d6a0e9/ALZ-21-e14269-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcf1/11775461/72dee13389b5/ALZ-21-e14269-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcf1/11775461/648cf5e9ffd2/ALZ-21-e14269-g001.jpg

相似文献

1
Heritability of Alzheimer's disease plasma biomarkers: A nuclear twin family design.阿尔茨海默病血浆生物标志物的遗传度:一项核孪生家族研究设计。
Alzheimers Dement. 2025 Jan;21(1):e14269. doi: 10.1002/alz.14269. Epub 2024 Nov 26.
2
The impact of kidney function on Alzheimer's disease blood biomarkers: implications for predicting amyloid-β positivity.肾功能对阿尔茨海默病血液生物标志物的影响:对预测淀粉样蛋白-β阳性的意义。
Alzheimers Res Ther. 2025 Feb 19;17(1):48. doi: 10.1186/s13195-025-01692-z.
3
Blood-based biomarkers for Alzheimer's disease in Down syndrome: A systematic review and meta-analysis.唐氏综合征中阿尔茨海默病的血液生物标志物:系统评价与荟萃分析
Alzheimers Dement. 2025 Apr;21(4):e70135. doi: 10.1002/alz.70135.
4
Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.阿尔茨海默病连续体中的血浆 Aβ42/40 比值、p-tau181、GFAP 和 NfL:AIBL 队列的横断面和纵向研究。
Alzheimers Dement. 2023 Apr;19(4):1117-1134. doi: 10.1002/alz.12724. Epub 2022 Jul 21.
5
Plasma biomarkers distinguish Boston Criteria 2.0 cerebral amyloid angiopathy from healthy controls.血浆生物标志物可将波士顿标准2.0版脑淀粉样血管病与健康对照区分开来。
Alzheimers Dement. 2025 Mar;21(3):e70010. doi: 10.1002/alz.70010.
6
Predicting Longitudinal Cognitive Decline and Alzheimer's Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers.基于血浆生物标志物预测轻度认知障碍患者的纵向认知下降和阿尔茨海默病转化。
Cells. 2024 Jun 22;13(13):1085. doi: 10.3390/cells13131085.
7
Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies.血浆淀粉样蛋白、P-tau、GFAP 和 NfL 与路易体痴呆患者脑脊液、临床和认知特征的关联。
Neurology. 2024 Jun 25;102(12):e209418. doi: 10.1212/WNL.0000000000209418. Epub 2024 Jun 3.
8
Association of plasma biomarkers of Alzheimer's disease and related disorders with cognition and cognitive decline: The MYHAT population-based study.阿尔茨海默病及相关疾病的血浆生物标志物与认知和认知衰退的关联:基于人群的 MYHAT 研究。
Alzheimers Dement. 2024 Jun;20(6):4199-4211. doi: 10.1002/alz.13829. Epub 2024 May 16.
9
Plasma Alzheimer's disease biomarker variability: Amyloid-independent and amyloid-dependent factors.血浆阿尔茨海默病生物标志物的变异性:不依赖淀粉样蛋白和依赖淀粉样蛋白的因素。
Alzheimers Dement. 2025 Jan;21(1):e14368. doi: 10.1002/alz.14368. Epub 2024 Nov 13.
10
Central autonomic network dysfunction and plasma Alzheimer's disease biomarkers in older adults.老年人的中枢自主神经网络功能障碍与阿尔茨海默病的血浆生物标志物。
Alzheimers Res Ther. 2024 Jun 8;16(1):124. doi: 10.1186/s13195-024-01486-9.

引用本文的文献

1
Heritability of Alzheimer-related plasma biomarkers in the Amish population.阿米什人群中阿尔茨海默病相关血浆生物标志物的遗传力。
medRxiv. 2025 May 21:2025.05.13.25327557. doi: 10.1101/2025.05.13.25327557.

本文引用的文献

1
The impact of kidney function on plasma neurofilament light and phospho-tau 181 in a community-based cohort: the Shanghai Aging Study.肾功能对社区人群血浆神经丝轻链和磷酸化 tau181 的影响:上海老龄化研究。
Alzheimers Res Ther. 2024 Feb 12;16(1):32. doi: 10.1186/s13195-024-01401-2.
2
The potential clinical value of plasma biomarkers in Alzheimer's disease.血浆生物标志物在阿尔茨海默病中的潜在临床价值。
Alzheimers Dement. 2023 Dec;19(12):5805-5816. doi: 10.1002/alz.13455. Epub 2023 Sep 11.
3
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa assays targeting distinct amyloid regions.
脑脊液和血浆 Aβ42/40 在阿尔茨海默病连续体中的变化:两种针对不同淀粉样蛋白区域的超高灵敏度 Simoa 检测方法的比较。
Clin Chem Lab Med. 2023 Sep 4;62(2):332-340. doi: 10.1515/cclm-2023-0659. Print 2024 Jan 26.
4
The heritability of blood-based biomarkers related to risk of Alzheimer's disease in a population-based sample of early old-age men.基于人群的老年早期男性样本中与阿尔茨海默病风险相关的基于血液的生物标志物的遗传力。
Alzheimers Dement. 2024 Jan;20(1):356-365. doi: 10.1002/alz.13407. Epub 2023 Aug 25.
5
Reference intervals for plasma amyloid-β, total tau, and phosphorylated tau181 in healthy elderly Chinese individuals without cognitive impairment.健康中国老年人无认知障碍者血浆淀粉样蛋白-β、总 tau 和磷酸化 tau181 的参考区间。
Alzheimers Res Ther. 2023 May 26;15(1):100. doi: 10.1186/s13195-023-01246-1.
6
Association of Chronic Kidney Disease With Plasma NfL and Other Biomarkers of Neurodegeneration: The H70 Birth Cohort Study in Gothenburg.慢性肾脏病与血浆 NfL 及其他神经退行性变生物标志物的关联:哥德堡 H70 出生队列研究。
Neurology. 2023 Jul 18;101(3):e277-e288. doi: 10.1212/WNL.0000000000207419. Epub 2023 May 24.
7
Plasma Biomarkers of Alzheimer's Disease: A Review of Available Assays, Recent Developments, and Implications for Clinical Practice.阿尔茨海默病的血浆生物标志物:现有检测方法、最新进展及对临床实践的意义综述
J Alzheimers Dis Rep. 2023 May 3;7(1):355-380. doi: 10.3233/ADR-230029. eCollection 2023.
8
Maximizing the value of twin studies in health and behaviour.最大化双胞胎研究在健康和行为中的价值。
Nat Hum Behav. 2023 Jun;7(6):849-860. doi: 10.1038/s41562-023-01609-6. Epub 2023 May 15.
9
What does heritability of Alzheimer's disease represent?阿尔茨海默病的遗传性代表什么?
PLoS One. 2023 Apr 28;18(4):e0281440. doi: 10.1371/journal.pone.0281440. eCollection 2023.
10
Plasma biomarkers for Alzheimer's disease: a field-test in a memory clinic.阿尔茨海默病的血浆生物标志物:记忆诊所的现场测试。
J Neurol Neurosurg Psychiatry. 2023 Jun;94(6):420-427. doi: 10.1136/jnnp-2022-330619. Epub 2023 Apr 3.